CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 45 enrolled
Drug / intervention
Xiidradrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04297618
NCT04297618Phase 4Completed
CompareCT.gov

The Effect of Xiidra on Comfort and Dryness in Symptomatic Contact Lens Wearers

University of Waterloo·interventional·Posted Mar 5, 2020·Updated May 4, 2025

In Brief

A Phase 4 clinical trial evaluating Xiidra for Dry Eye. Completed, enrolled 45 participants across 1 site.

Detailed Summary

The purpose of this study to evaluate changes in comfort and dryness in symptomatic contact lens (CL) wearers after using Xiidra (lifitegrast 5.0% ophthalmic solution) for 12 weeks.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye
CountriesCanada
CollaboratorsNovartis

Timeline

Phase 4CompletedFinished
2020202120222023202420252026
First PostedMar 5, 2020
Enrollment StartJul 7, 2021
Primary CompletionApr 18, 2024
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 6.3 years ago

Interventions

Xiidradrug

Xiidra (lifitegrast 5% ophthalmic solution)